Predicting Treatment Response in Inflammatory Bowel Diseases: Cross-Sectional Imaging Markers

Therapeutic options for inflammatory bowel diseases (IBD) have largely expanded in the last decades, both in Crohn’s disease and ulcerative colitis, including multiple biological drugs targeting different inflammation pathways. However, choosing the best treatment and timing for each patient is stil...

Descripción completa

Detalles Bibliográficos
Autores principales: Mignini, Irene, Maresca, Rossella, Ainora, Maria Elena, Larosa, Luigi, Scaldaferri, Franco, Gasbarrini, Antonio, Zocco, Maria Assunta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532020/
https://www.ncbi.nlm.nih.gov/pubmed/37762874
http://dx.doi.org/10.3390/jcm12185933

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532020/
https://www.ncbi.nlm.nih.gov/pubmed/37762874
http://dx.doi.org/10.3390/jcm12185933

Ejemplares similares